Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Wink

Showing results (111-120 of 124) with videos related to

Pageof 13
Sort By:
Journal of Psychiatric Research|October 11, 2014
Impact of acamprosate on plasma amyloid-β precursor protein in youth: a pilot analysis in fragile X syndrome-associated and idiopathic autism spectrum disorder suggests a pharmacodynamic protein markerCraig A Erickson, Balmiki Ray, Bryan Maloney, et al.
Journal of Autism and Developmental Disorders|July 10, 2020
Brief Report: Intranasal Ketamine in Adolescents and Young Adults with Autism Spectrum Disorder-Initial Results of a Randomized, Controlled, Crossover, Pilot StudyLogan K Wink, Debra L Reisinger, Paul Horn, et al.
Journal of Autism and Developmental Disorders|April 13, 2018
A Randomized Placebo-Controlled Cross-Over Pilot Study of Riluzole for Drug-Refractory Irritability in Autism Spectrum DisorderLogan K Wink, Ryan Adams, Paul S Horn, et al.
Scientific Reports|April 1, 2026
Acute and chronic dosing of the GABA A alpha 2,3 selective agonist BAER-101 do not alter behavior but may impact auditory-evoked EEG responses in adults with fragile X syndromeLisa A De Stefano, Hyeonseok Kim, Craig A Erickson, et al.
Molecular Autism|January 16, 2016
A randomized, placebo-controlled trial of D-cycloserine for the enhancement of social skills training in autism spectrum disordersNoha F Minshawi, Logan K Wink, Rebecca Shaffer, et al.
Translational Psychiatry|November 15, 2019
Motor cortex facilitation: a marker of attention deficit hyperactivity disorder co-occurrence in autism spectrum disorderErnest V Pedapati, Lindsey N Mooney, Steve W Wu, et al.
Journal of Autism and Developmental Disorders|November 16, 2019
Pediatric Quality of Life Inventory (PedsQL) in Fragile X SyndromeSarah E Fitzpatrick, Lauren M Schmitt, Ryan Adams, et al.
American Journal of Medical Genetics. Part A|July 30, 2015
The neurobehavioral and molecular phenotype of Angelman SyndromeLogan K Wink, Sarah Fitzpatrick, Rebecca Shaffer, et al.
Journal of Neurodevelopmental Disorders|June 15, 2024
Developmental milestones and daily living skills in individuals with Angelman syndromeAnjali Sadhwani, Sonya Powers, Anne Wheeler, et al.
Journal of Autism and Developmental Disorders|August 31, 2019
Pharmacologic Interventions for Irritability, Aggression, Agitation and Self-Injurious Behavior in Fragile X Syndrome: An Initial Cross-Sectional AnalysisEleanor M Eckert, Kelli C Dominick, Ernest V Pedapati, et al.
Pageof 13

Showing results (111-120 of 124) with videos related to

Sort By:
Pageof 13
Journal of Psychiatric Research|October 11, 2014
Impact of acamprosate on plasma amyloid-β precursor protein in youth: a pilot analysis in fragile X syndrome-associated and idiopathic autism spectrum disorder suggests a pharmacodynamic protein markerCraig A Erickson, Balmiki Ray, Bryan Maloney, et al.
Journal of Autism and Developmental Disorders|July 10, 2020
Brief Report: Intranasal Ketamine in Adolescents and Young Adults with Autism Spectrum Disorder-Initial Results of a Randomized, Controlled, Crossover, Pilot StudyLogan K Wink, Debra L Reisinger, Paul Horn, et al.
Journal of Autism and Developmental Disorders|April 13, 2018
A Randomized Placebo-Controlled Cross-Over Pilot Study of Riluzole for Drug-Refractory Irritability in Autism Spectrum DisorderLogan K Wink, Ryan Adams, Paul S Horn, et al.
Scientific Reports|April 1, 2026
Acute and chronic dosing of the GABA A alpha 2,3 selective agonist BAER-101 do not alter behavior but may impact auditory-evoked EEG responses in adults with fragile X syndromeLisa A De Stefano, Hyeonseok Kim, Craig A Erickson, et al.
Molecular Autism|January 16, 2016
A randomized, placebo-controlled trial of D-cycloserine for the enhancement of social skills training in autism spectrum disordersNoha F Minshawi, Logan K Wink, Rebecca Shaffer, et al.
Translational Psychiatry|November 15, 2019
Motor cortex facilitation: a marker of attention deficit hyperactivity disorder co-occurrence in autism spectrum disorderErnest V Pedapati, Lindsey N Mooney, Steve W Wu, et al.
Journal of Autism and Developmental Disorders|November 16, 2019
Pediatric Quality of Life Inventory (PedsQL) in Fragile X SyndromeSarah E Fitzpatrick, Lauren M Schmitt, Ryan Adams, et al.
American Journal of Medical Genetics. Part A|July 30, 2015
The neurobehavioral and molecular phenotype of Angelman SyndromeLogan K Wink, Sarah Fitzpatrick, Rebecca Shaffer, et al.
Journal of Neurodevelopmental Disorders|June 15, 2024
Developmental milestones and daily living skills in individuals with Angelman syndromeAnjali Sadhwani, Sonya Powers, Anne Wheeler, et al.
Journal of Autism and Developmental Disorders|August 31, 2019
Pharmacologic Interventions for Irritability, Aggression, Agitation and Self-Injurious Behavior in Fragile X Syndrome: An Initial Cross-Sectional AnalysisEleanor M Eckert, Kelli C Dominick, Ernest V Pedapati, et al.
Pageof 13